Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2008-03-25
2008-03-25
Davis, Zinna N. (Department: 1625)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C546S290000
Reexamination Certificate
active
11493070
ABSTRACT:
A compound selected from those of formula (I):wherein:n represents an integer from 1 to 6 inclusive,R1and R2represent a hydrogen atom, a (C1-C6)alkyl group or an aryl-(C1-C6)alkyl group,R3and R4represent a hydrogen atom or a (C1-C6)alkyl group,R5and R6represent a hydrogen atom, or a (C1-C6)alkyl, halogen, hydroxy, (C1-C6)alkoxy, cyano, nitro, (C2-C6)acyl, (C1-C6)alkoxycarbonyl, (C1-C6)trihaloalkyl, (C1-C6)trihaloalkoxy or optionally substituted amino group,its enantiomers, diastereoisomers and additional salts thereof with a pharmaceutically acceptable acid or base.Medicinal products containing the same which are useful in the treatment of conditions requiring a specific nicotinic ligand of α4β2 receptors.
REFERENCES:
patent: 1170281 (2002-01-01), None
French Preliminary Search Report for FR05.08033 of Jun. 12, 2006.
Charton Yves
Goldstein Solo
Guillonneau Claude
Lestage Pierre
Lockhart Brian
Davis Zinna N.
Hueschen and Sage
Les Laboratoires Servier
LandOfFree
Polysubstituted 1,1-pyridyloxycyclopropanamine compounds does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Polysubstituted 1,1-pyridyloxycyclopropanamine compounds, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Polysubstituted 1,1-pyridyloxycyclopropanamine compounds will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3955907